Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CardioMetrix is a specialized Contract Research Organization (CRO) providing preclinical and clinical research services with a focus on cardiovascular and metabolic diseases. Based in France, the company supports pharmaceutical, biotechnology, and medical device industries through experimental modeling, hemodynamic monitoring, and advanced imaging techniques. Their expertise spans a wide range of conditions, including heart failure, hypertension, and metabolic disorders, helping clients accelerate their drug discovery and development pipelines. CardioMetrix is recognized for its high-quality scientific consulting and tailored experimental protocols. The company offers a comprehensive suite of services from early-stage proof-of-concept studies to regulatory safety assessments. By leveraging state-of-the-art technologies like telemetry and echocardiography, they provide critical data for the evaluation of new therapeutic candidates.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CardioMetrix.